首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到10条相似文献,搜索用时 125 毫秒
1.
杨磊  张赟星  汪小琴 《应用化学》2018,35(7):781-787
为设计新型布洛芬缓释体系提供实验依据,以氯化镁、氯化铝、布洛芬(IBU)及淀粉等为原料,采取共沉淀-焙烧还原法及冷冻-解冻法,制备了层状双氢氧化物-布洛芬插层复合物(LDH-IBU)、淀粉凝胶-布洛芬复合物(淀粉凝胶-IBU)及层状双氢氧化物/淀粉凝胶-布洛芬插层复合物(LDH/淀粉凝胶-IBU)。通过傅里叶红外光谱仪(FT-IR)、X射线衍射仪(XRD)表征了上述3种复合物的结构,并研究了它们在模拟人体环境条件下的缓释性能。结果表明,3种复合物中的IBU在不同的缓释介质中都具有一定的缓释效果,复合物释放速率大小为:LDH/淀粉凝胶-IBULDH-IBU淀粉凝胶-IBU;在p H值为6.6和7.4以及0.9%生理盐水3种缓冲介质中释放速率依次减小。释放动力学均符合准一级动力学方程。  相似文献   

2.
Co‐polymeric hydrogels consisting of N‐vinyl‐2‐pyrrolidone (NVP) and acrylic acid (AAc) were synthesized and evaluated for release of a model drug, i.e., vitamin B12. Release studies in simulated gastric fluid (pH 1.2) and intestinal fluid (pH 7.4), at 37°C, showed the hydrogels to be pH sensitive. An in vitro release study by ‘traditional dissolution test’ (TDT) showed that percent drug released from the hydrogel was nearly 8.6±2.1 and 83.2±4.8 in the media of pH 1.2 and 6.8, respectively. However, in order to incorporate in vivo GI conditions such as acidic pH and high water content in the stomach, low water content and the presence of a semi–solid mass in the large intestine, a new test model, called flow through diffusion cell (FTDC) was also used. The two approaches yielded almost different release profiles. The gels were characterized by thermogravimetric analysis and FTIR spectroscopy.  相似文献   

3.
Methylacrylic acid/styrene cross-linked with divinylbenzene is a novel pH-sensitive ion exchange resin. Microspheres of this resin were characterized by Fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC). The microspheres showed a pulsatile swelling behavior when the pH of the media changed. The pH-sensitive microspheres were loaded with salbutamol sulfate and the drug-release characteristics were studied under both simulated gastric and intestinal pH conditions. The results obtained showed that the drug release also depended on the pH of the release media.  相似文献   

4.
聚L-谷氨酸担载胰岛素口服微球的制备与评价   总被引:1,自引:0,他引:1  
以聚L-谷氨酸为载体材料,采用无水乳液法制备了口服胰岛素微球,微球直径在5~20 μm,载药质量分数为5%~9%.载药微球具有良好的pH敏感释放行为,在胃模拟液中2 h释放量约为5%,在肠道模拟液中2 h释放90%以上.考察聚合物分子量、溶液浓度、理论投药量及混合材料对微球释放行为的影响.  相似文献   

5.
麦饭石含量对载药复合凝胶小球释药性能的影响   总被引:1,自引:0,他引:1  
以瓜尔胶-g-聚丙烯酸/麦饭石复合水凝胶(GG-g-PAA/MS)和海藻酸钠(SA)为原料,双氯芬酸钠(DS)为模拟药物,采用离子凝胶法制备了载药复合凝胶小球,考察了pH敏感性以及MS含量对复合凝胶小球的包封率、载药率、溶胀性和药物释放行为的影响.结果表明:凝胶小球具有明显的pH敏感性,在不同pH介质中溶胀率和释放速率...  相似文献   

6.
采用膜乳化-凝胶化法制备了粒径窄分布的海藻酸钙微球.用不同浓度的氯化钠溶液处理微球来调控微球中的自由羧酸根的含量.用原子吸收光谱和红外光谱表征了微球中钙、钠离子以及化学基团的变化,证明盐处理后海藻酸钙微球内发生了钠离子置换钙离子的过程,海藻酸中的羧酸根由螯合态转变为自由态.用盐处理后的微球吸附带正电荷的小分子抗癌药物阿霉素的能力大大提高,其中用浓度1.8%的氯化钠溶液处理后的微球载药量达到1310μg/mg,是未处理微球的10倍.负载药物的微球具有pH敏感的释放行为,在pH5.5的PBS溶液中的释放速率和释放量显著大于在pH 7.4的PBS溶液中.  相似文献   

7.
A facile and environmentally friendly approach has been developed to prepare yolk‐shell porous microspheres of calcium phosphate by using calcium L ‐lactate pentahydrate (CL) as the calcium source and adenosine 5′‐triphosphate disodium salt (ATP) as the phosphate source through the microwave‐assisted hydrothermal method. The effects of the concentration of CL, the microwave hydrothermal temperature, and the time on the morphology and crystal phase of the product are investigated. The possible formation mechanism of yolk‐shell porous microspheres of calcium phosphate is proposed. Hemoglobin from bovine red cells (Hb) and ibuprofen (IBU) are used to explore the application potential of yolk‐shell porous microspheres of calcium phosphate in protein/drug loading and delivery. The experimental results indicate that the as‐prepared yolk‐shell porous microspheres of calcium phosphate have relatively high protein/drug loading capacity, sustained protein/drug release, favorable pH‐responsive release behavior, and a high biocompatibility in the cytotoxicity test. Therefore, the yolk‐shell porous microspheres of calcium phosphate have promising applications in various biomedical fields such as protein/drug delivery.  相似文献   

8.
Chitosan/tripolyphosphate (CHIT/TPP) and chitosan/tripolyphosphate/chondroitin sulfate (CHIT/TPP/CHS) core-shell type microspheres were prepared by polyelectrolyte complexation in order to develop a biocompatible matrix for drug delivery. The continual method using a multi-loop reactor under sterile conditions was applied for microsphere preparation. All the types of microspheres produced were spherical in shape and had a porous structure. The mechanical resistance of the microspheres increased in the presence of CHS as the second polyanion, which toughened the microsphere shell structure. For a drug release application, the process of microsphere preparation was modified by dissolving ofloxacin (OFL), the fluoroquinolone antibiotic, in CHIT solution before complex formation. This study shows the difference in OFL release comparing the microspheres CHIT/TPP and CHIT/TPP/CHS and implies the potential to control this process.  相似文献   

9.
In present study, protein loaded poly (lactide-co-glycolide)/chitosan microspheres (PLGA/CS MSs) with spheres-in-sphere structure were prepared in order to weaken the burst release of protein from PLGA microspheres (PLGA MSs) and to buffer acidic micro-milieu. The PLGA MSs and PLGA/CS MSs were characterized in terms of their size distribution, morphology, drug-loading rate, zeta potential and physical-chemical properties. The incubation experiments of PLGA MSs and PLGA/CS MSs were manipulated in PBS solution at pH 7.4, 37 °C to monitor the release of BSA and the vehicles degradation. The release kinetic of BSA was illuminated mainly based on the degradation processes of the matrices. External CS crusts were proved to strikingly improve the release kinetic of the model protein by reducing initial burst release and extending continuous release while acting as a diffusion barrier. Moreover, using PLGA/CS MSs could avoid the decrease of pH value resulted from the acidic products of PLGA MSs because of the effective buffer action of the basic groups in CS. The results demonstrated that the spheres-in-sphere structure is an effective way to control the initial burst release of protein and to overcome the acidic problem of protein-loading PLGA MSs.  相似文献   

10.
CS/TPP纳米微胶囊的制备及其载药性能   总被引:5,自引:0,他引:5  
利用离子凝胶法, 以三聚磷酸钠(TPP)为交联剂, 由壳聚糖(CS)制备了CS/TPP纳米微胶囊. 用红外光谱仪、扫描电镜和粒径分析仪进行了表征, 并以牛血清蛋白(BSA)作为模型药物, 考察了所制备的CS/TPP纳米微胶囊的包载和缓释性能. 结果表明, CS/TPP纳米微胶囊的红外光谱相对于CS和TPP的红外光谱发生了很大变化, 说明CS和TPP通过正负电荷吸引聚合成囊; 粒径分析表明, 离子凝胶法可以得到粒径约430 nm的均匀分散的壳聚糖纳米微胶囊, 经冷冻干燥后粒径变为300 nm左右; 微胶囊包封率最高可达79.74%, 模型药物的持续释放时间可达7 d以上.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号